Norway Hearing Loss Disease Treatment Market Size & Outlook
Norway hearing loss disease treatment market, 2018-2030 (US$M)
Related Markets
Norway hearing loss disease treatment market highlights
- The Norway hearing loss disease treatment market generated a revenue of USD 201.4 million in 2023 and is expected to reach USD 276.4 million by 2030.
- The Norway market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
- In terms of segment, devices was the largest revenue generating product in 2023.
- Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Hearing loss disease treatment market data book summary
| Market revenue in 2023 | USD 201.4 million |
| Market revenue in 2030 | USD 276.4 million |
| Growth rate | 4.6% (CAGR from 2023 to 2030) |
| Largest segment | Devices |
| Fastest growing segment | Drugs |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Devices, Drugs |
| Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
Other key industry trends
- In terms of revenue, Norway accounted for 1.5% of the global hearing loss disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany hearing loss disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,083.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hearing Loss Disease Treatment Market Scope
Hearing Loss Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway hearing loss disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 91.01% in 2023. Horizon Databook has segmented the Norway hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
Technological advancements in hearing aids in Norway market is one of the key factors to accelerate the adoption of hearing aids. In March 2023, Cochlear entered into collaboration with the Norwaybased startup, Oculaudio, with an aim to develop hearing eyeglasses.
This new kind of hearing aid consists of 16 microphones that are mounted on frames of eyeglasses. Furthermore, in May 2022, Neuromod Devices, an Irish medical devices company specialized in treatment of tinnitus signed a strategic agreement with HOR AS, Norway’s major provider of hearing care and tinnitus.
Through this agreement, Neuromod Devices is expected to obtain access to Norway hearing care market. Moreover, the company has also launched its tinnitus care device in Norway.
Reasons to subscribe to Norway hearing loss disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway hearing loss disease treatment market databook
-
Our clientele includes a mix of hearing loss disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into Norway hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway hearing loss disease treatment market report size, by product, 2018-2030 (US$M)
Norway Hearing Loss Disease Treatment Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
